×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Back to Agenda
HOW TO OPTIMIZE DRUG DEVELOPMENT UP TO APPROVAL AND BEYOND - PARALLEL BREAKOUT SESSIONS WITH CASE STUDIES
Session Chair(s)
Martine Dehlinger-Kremer, PhD
VP Scientific Affairs, Pediatric SME, ICON Plc & President, EUCROF
Icon Plc, Germany
Have an account?